Organization Overview
Alternative names
alemtuzumab (campath) (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (3 trials)
allogeneic lymphocytes (1 trial)
allogeneic stem cells (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (4 trials)
blinatumomab (blincyto) (1 trial)
COVID-19 convalescent plasma (1 trial)
cyclophosphamide (cytoxan) (5 trials)
fludarabine (fludara) (8 trials)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Graft vs Host Disease (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lymphoma (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Nausea (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Preleukemia (Phase 2)
Syndrome (Phase 2)
Vomiting (Phase 2)